Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2009The American Journal of Surgical Pathology

Immunohistochemical Staining for CDX-2, PDX-1, NESP-55, and TTF-1 Can Help Distinguish Gastrointestinal Carcinoid Tumors From Pancreatic Endocrine and Pulmonary Carcinoid Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAmitabh SrivastavaMemorial Sloan Kettering Cancer Center
Jason L. Hornick
Jason L. HornickThe Wistar Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Srivastava et al. (2009) studied this question.

synapsesocial.com/papers/6a70f1c7f44fa9f079deb165https://doi.org/10.1097/pas.0b013e31818d7d8b
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases2008 · 154 citations
  2. 2NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids2003 · 37 citations
  3. 3Expression of the Intestinal Transcription Factor CDX2 in Carcinoid Tumors Is a Marker of Midgut Origin2006 · 72 citations
  4. 4Carcinoid Tumors1982 · 145 citations
  5. 5Pdx1 Level Defines Pancreatic Gene Expression Pattern and Cell Lineage Differentiation2001 · 173 citations